JP2006503077A5 - - Google Patents

Download PDF

Info

Publication number
JP2006503077A5
JP2006503077A5 JP2004540938A JP2004540938A JP2006503077A5 JP 2006503077 A5 JP2006503077 A5 JP 2006503077A5 JP 2004540938 A JP2004540938 A JP 2004540938A JP 2004540938 A JP2004540938 A JP 2004540938A JP 2006503077 A5 JP2006503077 A5 JP 2006503077A5
Authority
JP
Japan
Prior art keywords
alkyl
formula
compound
carbamoyl
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2004540938A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006503077A (ja
Filing date
Publication date
Priority claimed from GBGB0222909.4A external-priority patent/GB0222909D0/en
Application filed filed Critical
Publication of JP2006503077A publication Critical patent/JP2006503077A/ja
Publication of JP2006503077A5 publication Critical patent/JP2006503077A5/ja
Withdrawn legal-status Critical Current

Links

JP2004540938A 2002-10-03 2003-09-29 チエノピロール誘導体を製造するための方法および中間体 Withdrawn JP2006503077A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0222909.4A GB0222909D0 (en) 2002-10-03 2002-10-03 Novel process and intermediates
PCT/GB2003/004211 WO2004031193A1 (en) 2002-10-03 2003-09-29 Process and intermediates for the preparation of thienopyrrole derivatives

Publications (2)

Publication Number Publication Date
JP2006503077A JP2006503077A (ja) 2006-01-26
JP2006503077A5 true JP2006503077A5 (enExample) 2006-08-10

Family

ID=9945217

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004540938A Withdrawn JP2006503077A (ja) 2002-10-03 2003-09-29 チエノピロール誘導体を製造するための方法および中間体

Country Status (13)

Country Link
US (1) US7307174B2 (enExample)
EP (1) EP1549653A1 (enExample)
JP (1) JP2006503077A (enExample)
KR (1) KR20050061490A (enExample)
CN (1) CN1688588A (enExample)
AU (1) AU2003267656A1 (enExample)
BR (1) BR0314312A (enExample)
CA (1) CA2498843A1 (enExample)
GB (1) GB0222909D0 (enExample)
MX (1) MXPA05003387A (enExample)
NO (1) NO20051047L (enExample)
WO (1) WO2004031193A1 (enExample)
ZA (1) ZA200501742B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0205165D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205166D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205170D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205162D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205176D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205175D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0222912D0 (en) 2002-10-03 2002-11-13 Astrazeneca Ab Novel process and intermediates
GB0321003D0 (en) * 2003-09-09 2003-10-08 Angeletti P Ist Richerche Bio Compounds, compositions and uses
AU2004312530A1 (en) 2003-12-29 2005-07-21 Sepracor Inc. Pyrrole and pyrazole DAAO inhibitors
CA2636324C (en) 2006-01-06 2012-03-20 Sepracor Inc. Cycloalkylamines as monoamine reuptake inhibitors
US8053603B2 (en) 2006-01-06 2011-11-08 Sunovion Pharmaceuticals Inc. Tetralone-based monoamine reuptake inhibitors
US7884124B2 (en) 2006-06-30 2011-02-08 Sepracor Inc. Fluoro-substituted inhibitors of D-amino acid oxidase
WO2008083729A1 (en) * 2007-01-09 2008-07-17 Bayer Schering Pharma Aktiengesellschaft Radiolabelling via fluorination of aziridines
US7902252B2 (en) 2007-01-18 2011-03-08 Sepracor, Inc. Inhibitors of D-amino acid oxidase
JP5420534B2 (ja) 2007-05-31 2014-02-19 サノビオン ファーマシューティカルズ インク モノアミン再取り込み阻害薬としてのフェニル置換シクロアルキルアミン
CN106588868A (zh) * 2016-11-16 2017-04-26 武汉理工大学 一种2‑溴‑3‑噻吩甲酸中间体的合成方法

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU364613A1 (ru) 1970-11-27 1972-12-28 Всесоюзный научно исследовательский химико фармацевтический институт имени С. Орджоникидзе Способ получения производных 2-аминотиено-
GB9302622D0 (en) 1993-02-10 1993-03-24 Wellcome Found Heteroaromatic compounds
ES2211454T3 (es) 1999-09-30 2004-07-16 Pfizer Products Inc. Pirrolilamidas como inhibidores de la colageno fosforilasa.
ATE290865T1 (de) 1999-10-19 2005-04-15 Merck & Co Inc Tyrosin kinase inhibitoren
SE9903998D0 (sv) 1999-11-03 1999-11-03 Astra Ab New compounds
JP2001294572A (ja) * 2000-02-09 2001-10-23 Dai Ichi Seiyaku Co Ltd 新規スルホニル誘導体
EP1136071A3 (en) 2000-03-22 2003-03-26 Pfizer Products Inc. Use of glycogen phosphorylase inhibitors
GB0017676D0 (en) * 2000-07-19 2000-09-06 Angeletti P Ist Richerche Bio Inhibitors of viral polymerase
GB0021831D0 (en) 2000-09-06 2000-10-18 Astrazeneca Ab Chemical compounds
MXPA03000966A (es) 2002-02-28 2003-09-04 Pfizer Prod Inc Agentes antidiabeticos.
GB0205176D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205166D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205170D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205175D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205162D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205165D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
JPWO2003091213A1 (ja) 2002-04-25 2005-09-02 アステラス製薬株式会社 新規なアミド誘導体又はその塩
US7226938B2 (en) * 2002-09-06 2007-06-05 Janssen Pharmaceutica, N.V. Heterocyclic compounds
GB0222912D0 (en) 2002-10-03 2002-11-13 Astrazeneca Ab Novel process and intermediates
MXPA05004968A (es) 2002-11-07 2005-08-02 Pfizer Prod Inc N-(indol-z-carbonil)amidas como agentes anti-diabeticos.
US7098235B2 (en) * 2002-11-14 2006-08-29 Bristol-Myers Squibb Co. Triglyceride and triglyceride-like prodrugs of glycogen phosphorylase inhibiting compounds
JP2004196702A (ja) 2002-12-18 2004-07-15 Yamanouchi Pharmaceut Co Ltd 新規なアミド誘導体又はその塩
WO2004058715A1 (ja) 2002-12-25 2004-07-15 Daiichi Pharmaceutical Co., Ltd. ジアミン誘導体
WO2004092158A1 (en) 2003-04-17 2004-10-28 Pfizer Products Inc. Carboxamide derivatives as anti-diabetic agents
BRPI0409952A (pt) * 2003-04-30 2006-04-25 Pfizer Prod Inc agentes anti-diabéticos
WO2004113345A1 (ja) 2003-06-20 2004-12-29 Japan Tobacco Inc. 縮合ピロール化合物及びその医薬用途
GB0318463D0 (en) 2003-08-07 2003-09-10 Astrazeneca Ab Chemical compounds
GB0318464D0 (en) 2003-08-07 2003-09-10 Astrazeneca Ab Chemical compounds
GB0319759D0 (en) 2003-08-22 2003-09-24 Astrazeneca Ab Chemical compounds
GB0319690D0 (en) 2003-08-22 2003-09-24 Astrazeneca Ab Chemical compounds
WO2005020985A1 (en) 2003-08-29 2005-03-10 Astrazeneca Ab Indolamide derivatives which possess glycogen phosphorylase inhibitory activity
WO2005020986A1 (en) 2003-08-29 2005-03-10 Astrazeneca Ab Heterocyclic amide derivatives which posses glycogen phosphorylase inhibitory activity
GB0320422D0 (en) 2003-08-30 2003-10-01 Astrazeneca Ab Chemical compounds

Similar Documents

Publication Publication Date Title
JP2006503077A5 (enExample)
CA2438646A1 (en) Pyrimidine derivatives for inhibition of cell-proliferation
EG23719A (en) New process for the synthesis of (I S)-4,5-dimethoxy-1-(methylaminomethyl)-benzocyclobutane and addition salts thereof, and application in the synthesis of I V abradine and addition salts thereof witha pharmaceutically acceptable acid
DE50304702D1 (de) Verfahren zur Herstellung hochreaktiver Polyisobutene
DE60100750D1 (de) NEUE KRISTALLINE FORM VON N-[4-[2-(2-AMINO-4,7-DIHYDRO-4-OXO-3H-PYRROLO[2,3-d]-PYRIMIDIN-5-YL)ETHYL]BENZOYL]-L-GLUTAMINSÄURE UND VERFAHREN FÜR IHRE HERSTELLUNG
RU2001115829A (ru) Дикетон в качестве промежуточного продукта при получении 3-галоген-1н-пиразолов
DE60119283D1 (de) Verfahren zur herstellung von 3-hydroxypicolinsäure-derivaten
DE602004004663D1 (de) Verfahren zur herstellung von 2- (chinoxalin-5-ylsulfonylamino) -benzamid-verbindungen
CO5450243A1 (es) Derivados de 2,6-quinolinilo y 2,6-naftilo, procesos para su preparacion
JP2006505541A5 (enExample)
WO2007098030A8 (en) Selective n-sulfonylation of 2-amino trifluoroalkyl substituted alcohols
ATE356797T1 (de) Azidfreies verfahren zur herstellung von 1,2- diaminoverbindungen
DE602004002498D1 (de) Verfahren zur Herstellung von Mischoxiden
EA201270099A1 (ru) Транс-4-[[(5s)-5-[[[3,5-бис(трифторметил)фенил]метил](2-метил-2h-тетразол-5-ил)амино]-2,3,4,5-тетрагидро-7,9-диметил-1h-1-бензазепин-1-ил]метил]циклогексанкарбоновая кислота
DE60038560D1 (de) Verfahren zur fermentativen Herstellung von L-Arginin
DE60031391D1 (de) Verfahren zur herstellung von carbonsäuresalzen aus primären alkoholen
NO20071634L (no) Effektiv syntese av 4,5-dihydro-pyrazolo(3,4-C)pyrid-2-oner
JP2005500996A5 (enExample)
TR200200745T2 (tr) Fenilasetik asit türevleri için proses.
JP2007512259A5 (enExample)
MX2013007006A (es) Acoplamientos eficientes de peptidos y su uso en la sintesis y aislamiento de una sal trisodica de ciclopenta[g]quinazolina.
BRPI0510278A (pt) método para produzir compostos, produto, e, composto
DE60108668D1 (de) Verfahren zur herstellung von phenethylamin-derivaten
JP2008511618A5 (enExample)
DE60329036D1 (de) Ökologisches verfahren zur herstellung von brombenzol